학술논문
Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial
Document Type
Article
Author
Laviolette, Michel; Skjold, Tina; Nielsen, Læge Carl; Howarth, Peter; Russell, Richard J; Chachi, Latifa; FitzGerald, J Mark; Backer, Vibeke; Olivenstein, Ronald; Titlestad, Ingrid L; Ulrik, Charlotte Suppli; Harrison, Timothy; Singh, Dave; Chaudhuri, Rekha; Leaker, Brian; McGarvey, Lorcan; Siddiqui, Salman; Wang, Millie; Braddock, Martin; Nordenmark, Lars H; Cohen, David; Parikh, Himanshu; Colice, Gene; Brightling, Christopher E
Source
In The Lancet Respiratory Medicine July 2018 6(7):499-510
Subject
Language
ISSN
2213-2600